Jan L. Breslow
Jan L. Breslow publishes mostly in Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Cholesterol and Lipid Metabolism.
- World rank
- #17,457 of 7,710,434 ranked researchers
- Rank in United States
- #6,259 of 1,627,098
- Works
- 313
- Citations
- 37k
- Citations per work
- 117.5
What does Jan L. Breslow research?
Jan L. Breslow's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (30%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else12640.1%
- Health Sciences9430.0%
- Medicine9430.0%
- Life Sciences9429.9%
- 1Molecular Biology15% of their works
- 2Surgery15% of their works
- 3Endocrinology, Diabetes and Metabolism10% of their works
- 4Genetics9% of their works
- 5Cancer Research6% of their works
- 6Cardiology and Cardiovascular Medicine5% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cholesterol and Lipid Metabolism
- Cancer, Lipids, and Metabolism
- Genetic Associations and Epidemiology
- Peroxisome Proliferator-Activated Receptors
- Lipid metabolism and disorders
- Atherosclerosis and Cardiovascular Diseases
Which keywords describe Jan L. Breslow's research?
The keywords of their largest research topics: Atherosclerosis, Cholesterol, Statins, Diabetes, Obesity, Metabolic Syndrome, Metabolism and Cardiovascular Disease Prevention.
- Oxidized LDL
- Lipoprotein Lipase
- Peroxisome Proliferator-Activated Receptors
- Genome-Wide Association
- Lipid Metabolism
- SREBP
- Inflammation
- Cardiovascular Disease
- Cardiovascular Disease Prevention
- Metabolic Syndrome
- Diabetes
- Cholesterol
- Atherosclerosis
- Statins
- Obesity
- Metabolism
- Cholesterol-lowering
- Insulin Resistance
- LXR
- Fatty Acid Synthase
- Genetic Variation
- PPARs
- ANGPTL3
- Immune Response
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Atherosclerosis1684 topics
- Cholesterol1493 topics
- Statins1112 topics
- Diabetes972 topics
- Obesity972 topics
- Metabolic Syndrome962 topics
- Metabolism762 topics
- Cardiovascular Disease Prevention731 topic
- Cholesterol-lowering731 topic
- Cardiovascular Disease661 topic
- Insulin Resistance661 topic
- Inflammation582 topics
- LXR451 topic
- SREBP451 topic
- Fatty Acid Synthase381 topic
- Lipid Metabolism381 topic
- Genetic Variation311 topic
- Genome-Wide Association311 topic
- PPARs311 topic
- Peroxisome Proliferator-Activated Receptors311 topic
- ANGPTL3301 topic
- Lipoprotein Lipase301 topic
- Immune Response271 topic
- Oxidized LDL271 topic
Where does Jan L. Breslow work?
Jan L. Breslow's main affiliation in the publication record is Rockefeller University, United States.
How many publications and citations does Jan L. Breslow have?
OpenAlex counts 313 works and 36,765 citations for Jan L. Breslow, an h-index of 107, ranking #17,457 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jan L. Breslow. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.